<!doctype html><html lang=en-us dir=ltr><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta name=description content="For the past couple of weeks, the patent news has been saturated with reports and commentaries on the Board of Appeal decision in the CRISPR hearing (T 844/18). Many readers may not have the time and/or enthusiasm to read all of these articles. However, what this Kat lacks in time she makes up for in enthusiasm, and provides your post-hearing highlights:
First, a case refresh&amp;hellip;
The Broad Institute lost one of their fundamental CRISPR patents (EP2771468) in opposition because of a clear-cut case of invalid priority (IPKat: here)."><title>Aftermath of the CRISPR hearing - Highlights from the blogosphere</title><link rel=canonical href=https://Nexus-Security.github.io/posts/2016-09-09-aftermath-of-crispr-hearing-highlights/><link rel=stylesheet href=/scss/style.min.7dbfdd4b0c439bdacf631096fda79b869b5850a9d35a3f67b9a557f3010f3972.css><meta property="og:title" content="Aftermath of the CRISPR hearing - Highlights from the blogosphere"><meta property="og:description" content="For the past couple of weeks, the patent news has been saturated with reports and commentaries on the Board of Appeal decision in the CRISPR hearing (T 844/18). Many readers may not have the time and/or enthusiasm to read all of these articles. However, what this Kat lacks in time she makes up for in enthusiasm, and provides your post-hearing highlights:
First, a case refresh&amp;hellip;
The Broad Institute lost one of their fundamental CRISPR patents (EP2771468) in opposition because of a clear-cut case of invalid priority (IPKat: here)."><meta property="og:url" content="https://Nexus-Security.github.io/posts/2016-09-09-aftermath-of-crispr-hearing-highlights/"><meta property="og:site_name" content="0x000216"><meta property="og:type" content="article"><meta property="article:section" content="Posts"><meta property="article:published_time" content="2020-01-31T10:26:00+01:00"><meta property="article:modified_time" content="2020-01-31T10:26:00+01:00"><meta name=twitter:title content="Aftermath of the CRISPR hearing - Highlights from the blogosphere"><meta name=twitter:description content="For the past couple of weeks, the patent news has been saturated with reports and commentaries on the Board of Appeal decision in the CRISPR hearing (T 844/18). Many readers may not have the time and/or enthusiasm to read all of these articles. However, what this Kat lacks in time she makes up for in enthusiasm, and provides your post-hearing highlights:
First, a case refresh&amp;hellip;
The Broad Institute lost one of their fundamental CRISPR patents (EP2771468) in opposition because of a clear-cut case of invalid priority (IPKat: here)."></head><body class=article-page><script>(function(){const e="StackColorScheme";localStorage.getItem(e)||localStorage.setItem(e,"auto")})()</script><script>(function(){const t="StackColorScheme",e=localStorage.getItem(t),n=window.matchMedia("(prefers-color-scheme: dark)").matches===!0;e=="dark"||e==="auto"&&n?document.documentElement.dataset.scheme="dark":document.documentElement.dataset.scheme="light"})()</script><div class="container main-container flex on-phone--column extended"><aside class="sidebar left-sidebar sticky"><button class="hamburger hamburger--spin" type=button id=toggle-menu aria-label="Toggle Menu">
<span class=hamburger-box><span class=hamburger-inner></span></span></button><header><figure class=site-avatar><a href=/><img src=/img/avatar_hue825486955cd7c56d95e38b4bd2a8e3c_229979_300x0_resize_box_3.png width=300 height=300 class=site-logo loading=lazy alt=Avatar></a></figure><div class=site-meta><h1 class=site-name><a href=/>0x000216</a></h1><h2 class=site-description>Where Do Russian Hackers Store Their Exploits? 🤓 /ussr/bin/ 😋</h2></div></header><ol class=social-menu><li><a href=https://github.com/Nexus-Security target=_blank title=GitHub><svg width="72" height="72" viewBox="0 0 72 72" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="M36 72c19.882251.0 36-16.117749 36-36 0-19.882251-16.117749-36-36-36-19.882251 365231026e-23-36 16.117749-36 36C24348735e-22 55.882251 16.117749 72 36 72z" fill="#3e75c3"/><path d="M35.9985 12C22.746 12 12 22.7870921 12 36.096644c0 10.6440272 6.876 19.6751861 16.4145 22.8617681C29.6145 59.1797862 30.0525 58.4358488 30.0525 57.7973276 30.0525 57.2250681 30.0315 55.7100863 30.0195 53.6996482c-6.6765 1.4562499-8.085-3.2302544-8.085-3.2302544-1.0905-2.7829884-2.664-3.5239139-2.664-3.5239139C17.091 45.4500754 19.4355 45.4801943 19.4355 45.4801943c2.4075.1701719 3.675 2.4833051 3.675 2.4833051 2.142 3.6820383 5.6175 2.6188404 6.9855 2.0014024C30.3135 48.4077535 30.9345 47.3460615 31.62 46.7436831 26.2905 46.1352808 20.688 44.0691228 20.688 34.8361671c0-2.6308879.9345-4.781379 2.4705-6.4665327C22.911 27.7597262 22.0875 25.3110578 23.3925 21.9934585c0 0 2.016-.6475568 6.6 2.4697516C31.908 23.9285993 33.96 23.6620468 36.0015 23.6515052 38.04 23.6620468 40.0935 23.9285993 42.0105 24.4632101c4.581-3.1173084 6.5925-2.4697516 6.5925-2.4697516C49.9125 25.3110578 49.089 27.7597262 48.8415 28.3696344 50.3805 30.0547881 51.309 32.2052792 51.309 34.8361671c0 9.2555448-5.6115 11.29309-10.9575 11.8894446.860999999999997.7439374 1.629 2.2137408 1.629 4.4621184C41.9805 54.4089489 41.9505 57.0067059 41.9505 57.7973276 41.9505 58.4418726 42.3825 59.1918338 43.6005 58.9554002 53.13 55.7627944 60 46.7376593 60 36.096644 60 22.7870921 49.254 12 35.9985 12" fill="#fff"/></g></svg></a></li><li><a href=mailto:0x000216@gmail.com target=_blank title=Email><svg id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 512 512" style="enable-background:new 0 0 512 512"><path style="fill:#e6f3ff" d="M512 105.739v300.522c0 27.715-22.372 50.087-50.087 50.087H50.087C22.372 456.348.0 433.976.0 406.261V105.739c0-.89.0-1.781.111-2.671 1.336-25.6 21.704-45.969 47.304-47.304.89-.111 1.781-.111 2.671-.111h411.826c.89.0 1.892.0 2.783.111 25.489 1.336 45.857 21.704 47.193 47.193C512 103.847 512 104.849 512 105.739z"/><path style="fill:#cfdbe6" d="M464.696 55.763c-.892-.111-1.891-.111-2.783-.111H256v400.696h205.913c27.715.0 50.087-22.372 50.087-50.087V105.739c0-.89.0-1.892-.111-2.783C510.553 77.468 490.184 57.099 464.696 55.763z"/><path style="fill:#ff4b26" d="M511.889 102.957c-1.336-25.489-21.704-45.857-47.193-47.193C382.89 137.569 336.951 183.509 256 264.459 225.291 233.732 77.61 85.958 47.416 55.763c-25.6 1.336-45.969 21.704-47.304 47.304C0 103.958.0 104.849.0 105.739v300.522c0 27.715 22.372 50.087 50.087 50.087h16.696V169.739l165.621 165.51c6.456 6.567 15.026 9.795 23.597 9.795 8.57.0 17.141-3.228 23.597-9.795l165.621-165.621v286.72h16.696c27.715.0 50.087-22.372 50.087-50.087V105.739C512 104.849 512 103.847 511.889 102.957z"/><path style="fill:#d93f21" d="M279.596 335.249l165.621-165.621v286.72h16.696c27.715.0 50.087-22.372 50.087-50.087V105.739c0-.89.0-1.892-.111-2.783-1.336-25.489-21.704-45.857-47.193-47.193C382.891 137.569 336.951 183.509 256 264.459v80.584C264.57 345.043 273.141 341.816 279.596 335.249z"/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/></svg></a></li><li><a href=https://www.buymeacoffee.com/0x000216 target=_blank title=RSS><svg id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 512 512" style="enable-background:new 0 0 512 512"><path style="fill:#f78c20" d="M78.333 355.334C35.14 355.334.0 390.474.0 433.667S35.14 512 78.333 512s78.333-35.14 78.333-78.333-35.14-78.333-78.333-78.333z"/><g><path style="fill:#ffa929" d="M78.333 381.445c-28.795.0-52.222 23.427-52.222 52.222s23.427 52.222 52.222 52.222 52.222-23.427 52.222-52.222-23.427-52.222-52.222-52.222z"/><path style="fill:#ffa929" d="M477.918 264.861c-21.843-51.641-53.111-98.019-92.936-137.842-39.824-39.824-86.201-71.093-137.843-92.935C193.669 11.468 136.874.0 78.333.0c-4.807.0-8.704 3.897-8.704 8.704v85.519c0 4.807 3.897 8.704 8.704 8.704 182.37.0 330.74 148.369 330.74 330.74.0 4.807 3.897 8.704 8.704 8.704h85.52c4.807.0 8.704-3.897 8.704-8.704C512 375.126 500.533 318.331 477.918 264.861z"/><path style="fill:#ffa929" d="M78.333 163.853c-4.807.0-8.704 3.897-8.704 8.704v95.74c0 4.807 3.897 8.704 8.704 8.704 86.386.0 156.666 70.281 156.666 156.666.0 4.807 3.897 8.704 8.704 8.704h95.74c4.807.0 8.704-3.897 8.704-8.704.0-72.07-28.065-139.826-79.027-190.787-50.961-50.961-118.717-79.027-190.787-79.027z"/></g><g><path style="fill:#f78c20" d="M78.333 242.186c-2.918.0-5.817.076-8.704.206v25.905c0 4.807 3.897 8.704 8.704 8.704 86.386.0 156.666 70.281 156.666 156.666.0 4.807 3.897 8.704 8.704 8.704h25.905c.129-2.886.206-5.786.206-8.704.0-105.752-85.729-191.481-191.481-191.481z"/><path style="fill:#f78c20" d="M78.333 68.113c-2.91.0-5.81.042-8.704.11v26.001c0 4.807 3.897 8.704 8.704 8.704 182.37.0 330.74 148.369 330.74 330.74.0 4.807 3.897 8.704 8.704 8.704h26.001c.067-2.894.11-5.793.11-8.704C443.887 231.777 280.223 68.113 78.333 68.113z"/></g><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/></svg></a></li><li><a href target=_blank title=Slack><svg width="256" height="256" viewBox="0 0 256 256" xmlns="http://www.w3.org/2000/svg" preserveAspectRatio="xMidYMid"><path d="M165.964 15.838c-3.89-11.975-16.752-18.528-28.725-14.636-11.975 3.89-18.528 16.752-14.636 28.725l58.947 181.365c4.048 11.187 16.132 17.473 27.732 14.135 12.1-3.483 19.475-16.334 15.614-28.217L165.964 15.838" fill="#dfa22f"/><path d="M74.626 45.516C70.734 33.542 57.873 26.989 45.9 30.879 33.924 34.77 27.37 47.631 31.263 59.606l58.948 181.366c4.047 11.186 16.132 17.473 27.732 14.132 12.099-3.481 19.474-16.332 15.613-28.217L74.626 45.516" fill="#3cb187"/><path d="M240.162 166.045c11.975-3.89 18.526-16.75 14.636-28.726-3.89-11.973-16.752-18.527-28.725-14.636L44.708 181.632c-11.187 4.046-17.473 16.13-14.135 27.73 3.483 12.099 16.334 19.475 28.217 15.614l181.372-58.93" fill="#ce1e5b"/><path d="M82.508 217.27l43.347-14.084-14.086-43.352-43.35 14.09 14.089 43.347" fill="#392538"/><path d="M173.847 187.591c16.388-5.323 31.62-10.273 43.348-14.084l-14.088-43.36-43.35 14.09 14.09 43.354" fill="#bb242a"/><path d="M210.484 74.706c11.974-3.89 18.527-16.751 14.637-28.727-3.89-11.973-16.752-18.526-28.727-14.636L15.028 90.293C3.842 94.337-2.445 106.422.896 118.022c3.481 12.098 16.332 19.474 28.217 15.613l181.371-58.93" fill="#72c5cd"/><path d="M52.822 125.933c11.805-3.836 27.025-8.782 43.354-14.086-5.323-16.39-10.273-31.622-14.084-43.352l-43.36 14.092 14.09 43.346" fill="#248c73"/><path d="M144.16 96.256l43.356-14.088a546179.21 546179.21.0 00-14.089-43.36L130.07 52.9l14.09 43.356" fill="#62803a"/></svg></a></li><li><a href=https://www.buymeacoffee.com/0x000216 target=_blank title=Minds><svg id="Capa_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 512 512" style="enable-background:new 0 0 512 512"><g><g><path style="fill:#ffe1b2" d="M256 33.085C245.078 13.38 224.079.0 2e2.0c-23.781.0-45.57 13.293-56.594 34.184C115.711 41.602 96 66.977 96 96c0 .059.0.113.0.172-9.977 7.512-16 19.301-16 31.828.0 1.316.078 2.637.234 3.992C60.211 145.266 48 167.758 48 192c0 14.07 4.039 27.543 11.719 39.262C57.273 236.512 56 242.207 56 248c0 2.738.281 5.445.828 8.098C36.672 267.308 24 288.539 24 312c0 27.973 18.305 52.34 44.109 60.785C65.398 378.828 64 385.324 64 392c0 21.098 13.805 39.508 33.539 45.727C103.891 466.746 129.828 488 160 488c4.617.0 9.227-.512 13.766-1.527C181.992 502 198.141 512 216 512c16.687.0 31.396-8.567 40-21.523V33.085z"/></g><g><g><path style="fill:#ffb980" d="M264 256c-4.422.0-8-3.582-8-8 0-22.055-17.945-40-40-40-8.008.0-15.734 2.355-22.336 6.812-3.023 2.043-7.055 1.781-9.797-.652-3.156-2.809-8.477-6.16-15.867-6.16-4.422.0-8-3.582-8-8s3.578-8 8-8c7.711.0 15.234 2.293 21.719 6.539C197.773 194.246 206.758 192 216 192c30.875.0 56 25.121 56 56C272 252.418 268.422 256 264 256z"/></g></g><g><g><path style="fill:#ffb980" d="M120 120c18.977.0 36.875 7.312 50.414 20.594 3.141 3.09 8.203 3.047 11.312-.109 3.094-3.152 3.047-8.219-.109-11.312C165.07 112.941 143.187 104 120 104c-13.046.0-25.395 2.93-36.542 8.046C81.253 117.019 80 122.423 80 128c0 1.316.078 2.637.234 3.992-.094.062-.173.139-.267.202C91.423 124.501 105.193 120 120 120z"/></g></g><g><g><path style="fill:#ffb980" d="M216 360c0-4.418-3.578-8-8-8s-8 3.582-8 8c0 17.645-14.352 32-32 32-14.211.0-26.82-9.648-30.664-23.465-.703-2.512-2.578-4.523-5.039-5.395-2.453-.871-5.188-.492-7.305 1.02C114.094 371.906 101.305 376 88 376c-6.948.0-13.625-1.149-19.894-3.207-2.214 4.939-3.501 10.19-3.916 15.586C71.714 390.73 79.711 392 88 392c13.297.0 26.187-3.266 37.773-9.52C133.969 397.894 150.141 408 168 408c26.469.0 48-21.531 48-48z"/></g></g><g><path style="fill:#fdc88e" d="M488 312c0-23.461-12.672-44.691-32.828-55.902.547-2.652.828-5.359.828-8.098.0-5.793-1.273-11.488-3.719-16.738C459.961 219.543 464 206.07 464 192c0-24.242-12.211-46.734-32.234-60.008.156-1.355.234-2.676.234-3.992.0-12.527-6.023-24.316-16-31.828.0-.059.0-.113.0-.172.0-29.023-19.711-54.398-47.406-61.816C357.57 13.293 335.781.0 312 0c-24.08.0-45.078 13.38-56 33.085v457.391C264.604 503.433 279.313 512 296 512c17.859.0 34.008-10 42.234-25.527C342.773 487.488 347.383 488 352 488c30.172.0 56.109-21.254 62.461-50.273C434.195 431.508 448 413.097 448 392c0-6.676-1.398-13.172-4.109-19.215C469.695 364.34 488 339.973 488 312z"/></g><g><path style="fill:#f8ab6b" d="M272.008 151.199C272 151.465 272 151.734 272 152c0 26.469 21.531 48 48 48s48-21.531 48-48c0-4.418-3.578-8-8-8s-8 3.582-8 8c0 17.645-14.352 32-32 32s-32-14.355-32-32c0-2.184.219-4.359.656-6.465.492-2.395-.133-4.883-1.703-6.754-1.57-1.871-4.016-3.066-6.352-2.859-.453.012-.891.059-.602.078-13.234.0-24-10.766-24-24v31.813C260.673 147.348 266.061 149.988 272.008 151.199z"/></g><g><path style="fill:#f8ab6b" d="M296 328c9.242.0 18.219-2.246 26.281-6.539C328.765 325.707 336.289 328 344 328c4.422.0 8-3.582 8-8s-3.578-8-8-8c-7.391.0-12.711-3.352-15.867-6.16-2.742-2.434-6.766-2.695-9.797-.656C311.726 309.644 304 312 296 312c-22.055.0-40-17.945-40-40v39.116C266.174 321.517 280.337 328 296 328z"/></g><g><g><path style="fill:#f8ab6b" d="M431.765 131.992c.156-1.355.234-2.676.234-3.992.0-5.577-1.253-10.981-3.458-15.954C417.395 106.93 405.046 104 392 104c-4.422.0-8 3.582-8 8s3.578 8 8 8c14.807.0 28.577 4.501 40.032 12.194C431.939 132.131 431.859 132.054 431.765 131.992z"/></g></g><g><g><path style="fill:#f8ab6b" d="M447.81 388.38c-.415-5.396-1.702-10.647-3.916-15.586C437.624 374.85 430.948 376 424 376c-13.578.0-26.594-4.266-37.641-12.332-2.07-1.5-4.719-1.93-7.133-1.168-2.43.77-4.344 2.648-5.164 5.059C369.101 382.176 355.414 392 340 392c-4.422.0-8 3.582-8 8s3.578 8 8 8c18.875.0 35.961-10.191 45.094-26.156C396.976 388.512 410.258 392 424 392 432.288 392 440.285 390.73 447.81 388.38z"/></g></g></g><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/></svg></a></li><li><a href=https://www.buymeacoffee.com/0x000216 target=_blank title=Coffee><svg id="Capa_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 340 340" style="enable-background:new 0 0 340 340"><g id="XMLID_18_"><polygon id="XMLID_138_" style="fill:#dedde0" points="76.429,290 80,340 170,340 170,290"/><polygon id="XMLID_169_" style="fill:#dedde0" points="170,80 61.429,80 65,130 170,130"/><polygon id="XMLID_197_" style="fill:#acabb1" points="170,290 170,340 260,340 263.571,290"/><polygon id="XMLID_221_" style="fill:#acabb1" points="170,80 170,130 275,130 278.571,80"/><path id="XMLID_222_" style="fill:#ffda44" d="M170 260c-22.091.0-40-22.386-40-50s17.909-50 40-50v-30H65 50l10 160h16.429H170V260z"/><path id="XMLID_33_" style="fill:#ff9811" d="M170 130v30c22.091.0 40 22.386 40 50s-17.909 50-40 50v30h93.571H280l10-160h-15H170z"/><path id="XMLID_223_" style="fill:#50412e" d="M210 210c0-27.614-17.909-50-40-50v1e2c22.091.0 40-22.386 40-50z"/><path id="XMLID_224_" style="fill:#786145" d="M130 210c0 27.614 17.909 50 40 50V160c-22.091.0-40 22.386-40 50z"/><polygon id="XMLID_225_" style="fill:#50412e" points="278.571,80 300,80 300,40 260,40 260,0 80,0 80,40 40,40 40,80 61.429,80 170,80"/></g><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/><g/></svg></a></li></ol><ol class=menu id=main-menu><li><a href=/><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-home" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><polyline points="5 12 3 12 12 3 21 12 19 12"/><path d="M5 12v7a2 2 0 002 2h10a2 2 0 002-2v-7"/><path d="M9 21v-6a2 2 0 012-2h2a2 2 0 012 2v6"/></svg><span>Home</span></a></li><li><a href=/about/><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-user" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="12" cy="7" r="4"/><path d="M6 21v-2a4 4 0 014-4h4a4 4 0 014 4v2"/></svg><span>About Us</span></a></li><li><a href=/termsofservice/><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-pencil" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z" fill="none"/><path d="M4 20h4L18.5 9.5a1.5 1.5.0 00-4-4L4 16v4"/><line x1="13.5" y1="6.5" x2="17.5" y2="10.5"/></svg><span>Terms Of Service</span></a></li><li><a href=/privacypolicy/><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-archive" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><rect x="3" y="4" width="18" height="4" rx="2"/><path d="M5 8v10a2 2 0 002 2h10a2 2 0 002-2V8"/><line x1="10" y1="12" x2="14" y2="12"/></svg><span>Privacy Policy</span></a></li><div class=menu-bottom-section><li id=dark-mode-toggle><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-toggle-left" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="8" cy="12" r="2"/><rect x="2" y="6" width="20" height="12" rx="6"/></svg><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-toggle-right" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="16" cy="12" r="2"/><rect x="2" y="6" width="20" height="12" rx="6"/></svg><span>Dark Mode</span></li></div></ol></aside><main class="main full-width"><article class=main-article><header class=article-header><div class=article-details><div class=article-title-wrapper><h2 class=article-title><a href=/posts/2016-09-09-aftermath-of-crispr-hearing-highlights/>Aftermath of the CRISPR hearing - Highlights from the blogosphere</a></h2></div><footer class=article-time><div><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-calendar-time" width="56" height="56" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><path d="M11.795 21H5a2 2 0 01-2-2V7a2 2 0 012-2h12a2 2 0 012 2v4"/><circle cx="18" cy="18" r="4"/><path d="M15 3v4"/><path d="M7 3v4"/><path d="M3 11h16"/><path d="M18 16.496V18l1 1"/></svg><time class=article-time--published>Jan 31, 2020</time></div><div><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-clock" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="12" cy="12" r="9"/><polyline points="12 7 12 12 15 15"/></svg><time class=article-time--reading>8 minute read</time></div></footer></div></header><section class=article-content><p><strong>For the past couple of weeks, the patent news has been saturated with reports and commentaries on the Board of Appeal decision in the CRISPR hearing (T 844/18).</strong> Many readers may not have the time and/or enthusiasm to read all of these articles. However, what this Kat lacks in time she makes up for in enthusiasm, and provides your post-hearing highlights:</p><p><strong>First, a case refresh&mldr;</strong></p><p><a class=link href=https://1.bp.blogspot.com/-uXGOXk9xfYc/XjCqSC_46BI/AAAAAAAAJ6I/9PQJ1jsxHmM8CXDaRg-uh5puWR3UAKD6QCNcBGAsYHQ/s1600/cartoon-cute-cats-reading-news-vector.jpg target=_blank rel=noopener><img src=https://1.bp.blogspot.com/-uXGOXk9xfYc/XjCqSC_46BI/AAAAAAAAJ6I/9PQJ1jsxHmM8CXDaRg-uh5puWR3UAKD6QCNcBGAsYHQ/s320/cartoon-cute-cats-reading-news-vector.jpg loading=lazy></a></p><p>The Broad Institute lost one of their fundamental CRISPR patents (<a class=link href="https://register.epo.org/application?number=EP13818570" target=_blank rel=noopener><strong>EP2771468</strong></a>) in opposition because of a clear-cut case of invalid priority (IPKat: <a class=link href=http://ipkitten.blogspot.com/2018/01/epo-revokes-crispr-patent-clear-cut.html target=_blank rel=noopener><strong>here</strong></a>). <a class=link href=https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/ar87.html target=_blank rel=noopener><strong>Article 87 EPC</strong></a>, based on Article 4(1) of the <a class=link href=https://www.wipo.int/treaties/en/ip/paris/ target=_blank rel=noopener><strong>Paris Convention</strong></a>, specifies that any person who has filed a patent in a state party to the Paris Convention, or his successor in title, may claim priority from that application for the purposes of a subsequent EP application. The EPO interprets “any person” as meaning that all the applicants (or their successors in title) named on the priority application must be named on the subsequent EP application. The Broad Institute lost their CRISPR patent at opposition because an inventor of the US provisional application from which priority was claimed (or his successor in title) was not named on the PCT application.</p><p><strong>News review</strong></p><p>On appeal (T 844/18) the Broad Institute argued that the EPO&rsquo;s approach to priority was incorrect. The patentee’s arguments may be summarised as follows: (I) Entitlement to priority should not be assessed by the EPO, (II) the EPO incorrectly interprets the phrase “any person” in <a class=link href=https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/ar87.html target=_blank rel=noopener><strong>Article 87 EPC</strong></a> and Article 4 Paris Convention, and (III) US law should govern the interpretation of “any applicant” in <a class=link href=https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/ar87.html target=_blank rel=noopener><strong>Article 87 EPC</strong></a> when the priority application is a US provisional.</p><p>After hearing lengthy submissions on each of these arguments from the patentee and opponents, the Board of Appeal dismissed the Broad Institute&rsquo;s appeal. The Board of Appeal thus upheld the opposition decision that the priority claim was invalid, and that consequently the patent lacked novelty.</p><p><strong>The patentee</strong></p><p>Understandably, those on the winning side of the appeal have been most vocal with their opinions on the outcome. Conversely, law firms supporting the Broad Institute (including De Clerq, Bird & Bird and Brinkhof) have not provided any commentary. However, the Broad Institute itself issued a **<a class=link href=https://www.broadinstitute.org/crispr/journalists-statement-and-background-crispr-patent-process target=_blank rel=noopener>statement</a>**on the day of the decision. The Broad Institute <strong><a class=link href=https://www.broadinstitute.org/crispr/journalists-statement-and-background-crispr-patent-process target=_blank rel=noopener>echoed its previous statements</a></strong> that their patent had been dismissed by the Board of Appeal due to a “technical formality”. They were also eager to point out that “the majority of Broad’s CRISPR-Cas9 patents in Europe are not affected by this decision”. Licences for CRISPR technology in Europe are therefore likely to be largely unaffected by the Board of Appeal decision. </p><p>The Broad Institute further did not waste an opportunity to take a dig at University of California Berkeley (UCB), their main rival in the CRISPR patent dispute. The Broad mentioned that they have “for seven years…made many attempts to engage University of California-Berkeley, directly and through their exclusive licensee and through patent pools. These efforts began before UCB licensed its IP exclusively and entirely to commercial entities”. Whilst the revocation of the Broad Institute patent **<a class=link href="https://register.epo.org/application?number=EP13818570" target=_blank rel=noopener>EP2771468</a> **is not a knock out blow, it will undoubtedly strengthen the side of UCB in any future negotiations. </p><p><strong>The opponents</strong></p><p>The representative for Opponent 1, <strong><a class=link href=http://www.schlich.co.uk/ target=_blank rel=noopener>George Schlich</a></strong>, has published <strong><a class=link href=http://www.schlich.co.uk/latest-epo-technical-board-appeal.php target=_blank rel=noopener>an in-depth review</a></strong> of the outcome of the hearing. From the point of view of many commentators, the simple take-home message from the hearing was that existing case law was followed. Schlich argues that the written decision of the Board will provide something more fundamental: “we will now get a more enunciated reasoning as to why the law and practice is correct and settled”.</p><p>Schlich notes that the argument from the Broad Institute that received the most attention was the that &ldquo;any person&rdquo; in <a class=link href=https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/ar87.html target=_blank rel=noopener><strong>Article 87(1) EPC</strong></a> and Article 4(1) of the Paris Convention should be interpreted as &ldquo;any one of&rdquo; the applicants of the priority application. The Broad Institute had submitted a declaration from no-less eminent a person than Lord Neuberger to support their interpretation of &ldquo;any&rdquo;. According to Schlich, at the hearing the Broad Institute also referred to recent EPO law indicating that right to claim priority cannot be exhausted (<a class=link href=https://www.epo.org/law-practice/case-law-appeals/recent/t010015ep1.html target=_blank rel=noopener><strong>T15/01</strong></a>). However, the Board of Appeal agreed with the Opponents that the right of priority is a single, indivisible right. Thus, the Board of Appeal concluded that the right cannot be divided or separated into multiple priority rights. Schlich makes the very pertinent point that the position of the EPO on this issue may henceforth be supported by the written rationale of Board of Appeal 3.3.08 (once we have the written decision), as opposed to a mere reliance on the argument that this just how it has always been done at the EPO.</p><p><strong>The patent press</strong></p><p>The appeal hearing attracted considerable coverage from parties not directly involved in proceedings. Those unlucky enough not to be able to attend in person were able to follow the semi-live tweets from observers. However, followers of the live reports will have been reminded of the old adage “it is not over until its over”, as reports that the Board of Appeal had referred questions on priority to the EBA, later proved incorrect [<strong>Merpel was particularly amused by the backtracking of certain patent news-outlets with regards to the &ldquo;EBA referral&rdquo; incident. Those reporting that the Board of Appeal had decided to refer, were subsequently forced to report a &ldquo;dramatic reversal&rdquo; that the Board no longer intended to refer</strong>]. </p><p>Kilburn & Strode LLP (K&S) were very active commentators. In their <strong><a class=link href=https://www.kilburnstrode.com/knowledge/european-ip/boards-crispr-decision target=_blank rel=noopener>report of the proceedings</a></strong>, K&S argued that the decision of the Board of Appeal may not, in fact, be the end of the matter. During the hearing, the Broad Institute had objected that there had not been adequate discussion on the decision of the Board of Appeal not to refer the questions on priority to the EBA. K&S propose that the Broad Institute may file a petition for review, on the grounds that there has been a fundamental violation of the Patentees’ right to be heard. The Enlarged Board of Appeal rarely find Petitions of Review admissible. Even when admitted, the majority of Petitions are usually rejected. </p><p>JUVE patent <strong><a class=link href=https://www.juve-patent.com/news-and-stories/cases/epo-revokes-broad-institute-patent-but-its-just-the-beginning-for-crispr-cas/ target=_blank rel=noopener>summarises</a></strong> all of the parties involved in the European dispute. These included the experts called on to give their opinion of the case. In support of the Broad Institute, “Former UK Supreme Court judges David Neuberger and Leonard Hoffman, Matrix Chambers barrister Phillipe Sands, Joseph Straus, former chair of a EPO Board of Appeal Ursula Kinkeldey, and Swiss Federal Patent Court judge Tobias Bremi”, whilst on the side of the opponents “former German Supreme Court judge Klaus-Jürgen Melullis, former director of the United States Patent and Trademark Office David Kappos, and Rudolf Teschemacher, former chair of a Board of Appeal”.</p><p>Another welcome addition to the commentary is provided by <a class=link href=https://www.novagraaf.com/fr/node/945 target=_blank rel=noopener>Novagraaf</a>, who take the opportunity to remind readers of the pitfalls that exist for US applicants of a European patent application. The US has less stringent priority requirements than the EPO. This is because the US understands priority as applying to inventions. Thus, a priority claim is valid in the US if the priority application and the application claiming priority has merely one inventor in common. Therefore, when a US provisional application is filed in the name of an inventor, in the US the inventor does not need to assign their rights to the applicant of the PCT application prior to the PCT filing date.</p><p>The Broad Institute is not alone in falling foul of the trap opened up by the differences in the US and European requirements for a valid priority claim. However, whilst not uncommon, the Broad Institute&rsquo;s error is remarkable for the magnitude of its commercial implications. In view of this, the decision of the Board of Appeal not to refer the issue of priority to the Enlarged Board of Appeal has been welcomed by many practitioners as a triumph of the rule of law over commercial interest and influence.</p><p><strong>The EPO</strong></p><p>The minutes of oral proceedings have now been <a class=link href="https://register.epo.org/application?documentId=E4CEFP4O3767DSU&number=EP13818570&lng=en&npl=false" target=_blank rel=noopener><strong>published</strong></a>. The minutes are a summary, as opposed to a transcript of proceedings. The minutes confirm that at the start of Day 3, the Board stated that they were then of the view that certain question of law concerning priority should be referred to the EBA (IPKat: <a class=link href="http://ipkitten.blogspot.com/2020/01/crispr-hearing-days-2-3-board-of-appeal.html?_sm_au_=iVVMvTFQn2sQHR56pGsWvKttvN1NG" target=_blank rel=noopener><strong>here</strong></a>). The minutes do not detail what changed the Board of Appeal&rsquo;s mind on the matter of the referral. The minutes merely mention that the referral was discussed with the parties. Unsubstantiated rumour has it that members of the EBA were seen lurking in the corridors of the EPO, perhaps keeping an eye on developments? The Board of Appeal came to their decision to dismiss the appeal on the fourth day (of the 5 days scheduled), following 2 hours 40 minutes of deliberation over lunch: (IPKat: <a class=link href="http://ipkitten.blogspot.com/2020/01/crispr-hearing-days-2-3-board-of-appeal.html?_sm_au_=iVVMvTFQn2sQHR56pGsWvKttvN1NG" target=_blank rel=noopener><strong>here</strong></a>).</p><p>We now await the written decision of the Board of Appeal, which will provide their reasoning in full.</p><p><strong>Further reading:</strong></p><ul><li>The opposition decision: <strong><a class=link href=http://ipkitten.blogspot.com/2018/01/epo-revokes-crispr-patent-clear-cut.html target=_blank rel=noopener>EPO revokes CRISPR patent – a clear cut case of invalid priority?</a></strong></li><li>The mysterious declaration: <strong><a class=link href=http://ipkitten.blogspot.com/2018/06/the-broads-crispr-patent-curious-case.html target=_blank rel=noopener>The Broad&rsquo;s CRISPR patent: The curious case of the missing declaration</a></strong></li><li>The statement of grounds of appeal: <strong><a class=link href=http://ipkitten.blogspot.com/2019/03/should-everyone-else-change-or-just.html target=_blank rel=noopener>&ldquo;Should everyone else change, or just the Patentee?&rdquo;: Progress of the Broad&rsquo;s CRISPR appeal</a></strong></li><li>The Board of Appeal&rsquo;s preliminary opinion: <strong><a class=link href=http://ipkitten.blogspot.com/2019/10/breaking-board-of-appeal-provides-some.html target=_blank rel=noopener>BREAKING: Board of Appeal provides some initial thoughts on the Broad Institute’s CRISPR appeal (T0844/18)</a></strong></li><li>Hearing, Day 1: <strong><a class=link href=http://ipkitten.blogspot.com/2020/01/the-broad-institutes-crispr-patent.html target=_blank rel=noopener>The Broad Institute&rsquo;s CRISPR patent appeal hearing: Day 1, Setting the Stage</a></strong></li><li>Hearing, Day 2-3: <strong><a class=link href=http://ipkitten.blogspot.com/2020/01/crispr-hearing-days-2-3-board-of-appeal.html target=_blank rel=noopener>CRISPR hearing days 2-3: Board of Appeal poised to refer to the EBA?</a></strong></li><li>Hearing, Day 4: <a class=link href=http://ipkitten.blogspot.com/2020/01/crispr-hearing-day-4-still-clear-cut.html target=_blank rel=noopener><strong>CRISPR hearing Day 4: Still a clear cut case of invalid priority, Broad Institute&rsquo;s appeal dismissed</strong></a></li></ul></section><footer class=article-footer><section class=article-copyright><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-copyright" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="12" cy="12" r="9"/><path d="M14.5 9a3.5 4 0 100 6"/></svg><span>Licensed under CC BY-NC-SA 4.0</span></section></footer></article><footer class=site-footer><section class=copyright>&copy;
2020 -
2022 0x000216</section><section class=powerby>Built with <a href=https://gohugo.io/ target=_blank rel=noopener>Hugo</a><br>Theme <b><a href=https://github.com/CaiJimmy/hugo-theme-stack target=_blank rel=noopener data-version=3.11.0>Stack</a></b> designed by <a href=https://jimmycai.com target=_blank rel=noopener>Jimmy</a></section><script data-name=BMC-Widget src=https://cdn.buymeacoffee.com/widget/1.0.0/prod/widget.prod.min.js data-id=0x000216 data-description=coffee! data-message=coffee! data-color=#FF813F data-position=right data-x_margin=28 data-y_margin=18></script></footer><div class=pswp tabindex=-1 role=dialog aria-hidden=true><div class=pswp__bg></div><div class=pswp__scroll-wrap><div class=pswp__container><div class=pswp__item></div><div class=pswp__item></div><div class=pswp__item></div></div><div class="pswp__ui pswp__ui--hidden"><div class=pswp__top-bar><div class=pswp__counter></div><button class="pswp__button pswp__button--close" title="Close (Esc)"></button>
<button class="pswp__button pswp__button--share" title=Share></button>
<button class="pswp__button pswp__button--fs" title="Toggle fullscreen"></button>
<button class="pswp__button pswp__button--zoom" title="Zoom in/out"></button><div class=pswp__preloader><div class=pswp__preloader__icn><div class=pswp__preloader__cut><div class=pswp__preloader__donut></div></div></div></div></div><div class="pswp__share-modal pswp__share-modal--hidden pswp__single-tap"><div class=pswp__share-tooltip></div></div><button class="pswp__button pswp__button--arrow--left" title="Previous (arrow left)"></button>
<button class="pswp__button pswp__button--arrow--right" title="Next (arrow right)"></button><div class=pswp__caption><div class=pswp__caption__center></div></div></div></div></div><script src=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/photoswipe.min.js integrity="sha256-ePwmChbbvXbsO02lbM3HoHbSHTHFAeChekF1xKJdleo=" crossorigin=anonymous defer></script><script src=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/photoswipe-ui-default.min.js integrity="sha256-UKkzOn/w1mBxRmLLGrSeyB4e1xbrp4xylgAWb3M42pU=" crossorigin=anonymous defer></script><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/default-skin/default-skin.css integrity="sha256-c0uckgykQ9v5k+IqViZOZKc47Jn7KQil4/MP3ySA3F8=" crossorigin=anonymous><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/photoswipe.css integrity="sha256-SBLU4vv6CA6lHsZ1XyTdhyjJxCjPif/TRkjnsyGAGnE=" crossorigin=anonymous></main></div><script src=https://cdn.jsdelivr.net/npm/node-vibrant@3.1.5/dist/vibrant.min.js integrity="sha256-5NovOZc4iwiAWTYIFiIM7DxKUXKWvpVEuMEPLzcm5/g=" crossorigin=anonymous></script><script type=text/javascript src=/ts/main.js defer></script>
<script>(function(){const e=document.createElement("link");e.href="https://fonts.googleapis.com/css2?family=Lato:wght@300;400;700&display=swap",e.type="text/css",e.rel="stylesheet",document.head.appendChild(e)})()</script></body></html>